Wake Forest Study To Look At Quality of Life In Long-Term Breast Cancer Survivors

October 12, 1998

WINSTON-SALEM, N.C. -- As the number of long-term survivors of cancer continues to grow, the medical community is becoming more concerned about issues of survivorship and quality of life and a new study will examine these issues.

"Breast cancer survivors face issues related to spiritual, physical, economic and psychosocial issues," said Electra D. Paskett, Ph.D., associate professor of public health sciences (epidemiology) at the Wake Forest University School of Medicine. "These issues have not been well-studied in terms of incidence, duration and impact on overall health-related quality of life as a survivor."

She added, "Issues of survivorship are especially important in breast cancer due to the increased use of mammography and the increasing number of younger women being diagnosed."

Paskett is the principal investigator of the new two-year study, paid for with a $276,332 grant from the National Institute on Aging.

"These women 'survive' the immediate crisis involving the diagnosis and treatment and enter into a new chronic phase of survivorship that involves lifelong utilization of medical resources, psychological effects, changes in social relationships and economic impacts," Paskett said.

The study will examine the prevalence of reproductive problems, early menopause, osteoporosis, the effect of the chemotherapy on the heart, post-surgery pain, fatigue, and weight gain.

For instance, more than half the women treated with chemotherapy following surgery will have chemically induced menopause. But estrogen replacement therapy, which ordinarily provides women with relief from menopausal symptoms, is controversial in women with a history of breast cancer, Paskett said.

Osteoporosis is another potential problem. Following chemotherapy-induced ovarian failure, some studies have found significant decreases in bone mineral density -- an indication that osteoporosis is occurring. But sizable surverys of the prevalence and effect of osteoporosis in breast cancer survivors do not exist. Tamoxifen, which is used to decrease the risk of breast cancer recurrence, may also help prevent loss of bone density. So might estrogen replacement therapy.

The investigators will look at the benefits of "lumpectomy" -- removal of only the lump and surrounding tiessue (instead of the whole breast) -- or reconstructive surgery to reduce the permanent scarring and disfiguring of the breast.

They will explore the economic consequences of breast cancer. Paskett noted that some previous studies have suggested that women who had had breast cancer have difficulties in making enough money to meet their needs, that health insurance was often difficult to obtain, and that some women reported difficulties at work.

Psychological issues include anxiety over the future, loneliness, depression, anger, guilt, fear about recurrence and body image changes. Often these are accompanied by marital and relationship stress, isolation and changes in social support.

Based on the findings, the investigators will develop and pilot test a telephone-based counseling intervention for long-term breast cancer survivors.

They will randomly select 400 disease-free breast cancer survivors who are 8-13 years post diagnosis and who have participated in a particular clinical trial of the Cancer and Leukemia Group B, a major national cancer clinical trials cooperative group composed of 200 institutions from both academic medical centers and community hospitals.

The women in this group have had combination therapy using cyclophosphamide, Adriamycin and 5-fluorouracil. Paskett said about half the women were premenopausal at the time of diagnosis.

The results of the project will be used to find ways of reducing the physical, psychosocial, spiritual and economic consequences of the diagnosis and treatment of breast cancer on those women who become long-term survivors.

Contact: Robert Conn, Jim Steele or Mark Wright at (336) 716-4587

Wake Forest University

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.